Pictet Asset Management (Switzerland)’s Supernus Pharmaceuticals SUPN Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$23.4M	Buy	777,962 +166,864	+27%	+$5.84M	0.03%	430
2023 Q1	$22.1M	Buy	611,098 +388,589	+175%	+$14.9M	0.03%	442
2022 Q4	$7.94M	Buy	222,509 +58,661	+36%	+$2.04M	0.01%	641
2022 Q3	$5.55M	Buy	163,848 +34,784	+27%	+$1.13M	0.01%	711
2022 Q2	$3.73M	Buy	129,064 +15,264	+13%	+$437K	0.01%	823
2022 Q1	$3.68M	Sell	113,800 -11,412	-9%	-$350K	﹤0.01%	869
2021 Q4	$3.65M	Sell	125,212 -35,239	-22%	-$1.07M	﹤0.01%	897
2021 Q3	$4.28M	Buy	+160,451	New	+$4.31M	﹤0.01%	867

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s SUPN Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Supernus Pharmaceuticals (SUPN) stake by 27% in Q2 2023, buying an estimated $5.84M and bringing the position to 777,962 shares worth $23.4M. The position accounts for 0.03% of the portfolio, ranked #430.

Pictet Asset Management (Switzerland) first reported a position in SUPN in Q3 2021 and has held it in 8 quarters since. 249 funds tracked by Wall St. Rank hold SUPN as of Q2 2023.

Pictet Asset Management (Switzerland) held 777,962 shares of Supernus Pharmaceuticals worth $23.4M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 166,864 Supernus Pharmaceuticals shares in Q2 2023, an estimated $5.84M.
Supernus Pharmaceuticals made up 0.03% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #430 holding.
Pictet Asset Management (Switzerland) first reported a position in Supernus Pharmaceuticals in Q3 2021 and has held it in 8 quarters since.
249 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.